Teduglutide (ALX-0600)

DRUG2 trials

Sponsors

Shire, Meyer Children's Hospital IRCCS

Conditions

Crohn's DiseaseShort Bowel Syndrome (SBS)

Phase 2

Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008

CompletedNCT00308438

ShireCrohn's Disease

Start: 2004-03-01End: 2006-06-01Updated: 2021-05-14

Unknown Phase

TED_ORG: Study on Short Bowel Syndrome

RecruitingNCT07400783

Meyer Children's Hospital IRCCSShort Bowel Syndrome (SBS)

Start: 2024-10-30End: 2026-10-01Target: 50Updated: 2026-02-10